Skorpios Trust

Holdings History for Stoke Therapeutics, Inc. - Common Stock (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 6.91M shares
Security Ownership: 13%

Shares, Excluding Options vs Price

Value, Excluding Options

Skorpios Trust ownership in Stoke Therapeutics, Inc. Common Stock (STOK)

2024-12-27 - Skorpios Trust has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.91M shares of Stoke Therapeutics, Inc. Common Stock (STOK). This represents 13% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Skorpios Trust	13%		$58.8M	6.91M			$8.52	13D/A	12/23/2024	27 Dec 2024 17:23:14

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	99.8%	-28.9%	$76.2M	6.91M	-2,000,000	-22.5%	$11.03	Q4 2024
9/30/2024	99.8%	-21.7%	$109M	8.91M	-1,937,500	-17.9%	$12.29	Q3 2024
6/30/2024	99.9%	-24.9%	$146M	10.8M	-3,600,000	-24.9%	$13.51	Q2 2024
3/31/2024	99.9%		$195M	14.4M			$13.50	Q1 2024
12/31/2023	99.8%		$76M	14.4M			$5.26	Q4 2023
9/30/2023	99.8%		$56.9M	14.4M			$3.94	Q3 2023
6/30/2023	66.7%		$154M	14.4M			$10.63	Q2 2023
3/31/2023	48.6%		$120M	14.4M			$8.33	Q1 2023
12/31/2022	42.4%		$133M	14.4M			$9.23	Q4 2022
9/30/2022	52.3%		$185M	14.4M			$12.84	Q3 2022
6/30/2022	79.8%		$191M	14.4M			$13.21	Q2 2022
3/31/2022	81%		$304M	14.4M			$21.05	Q1 2022
12/31/2021	76.7%		$347M	14.4M			$23.99	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.